The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer

<p>Abstract</p> <p>Background</p> <p>Several classification systems are available to assess pathological response to neoadjuvant chemotherapy in breast cancer, but reliable biomarkers to predict the efficiency of primary systemic therapy (PST) are still missing. Deregulation of gap junction channel...

Descripció completa

Dades bibliogràfiques

Autors principals:	Teleki Ivett, Krenacs Tibor, Szasz Marcell A, Kulka Janina, Wichmann Barna, Leo Cornelia, Papassotiropoulos Barbel, Riemenschnitter Cosima, Moch Holger, Varga Zsuzsanna
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2013-02-01
Col·lecció:	BMC Cancer
Matèries:	Breast cancer Connexin Gap junction Preoperative chemotherapy Prognosis
Accés en línia:	http://www.biomedcentral.com/1471-2407/13/50
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!